Markets are flat as investors await Nvidia's earnings, with expectations of strong AI-driven growth fueling anticipation. Trump's attempt to remove Fed Governor Lisa Cook raises concerns about central bank independence and could signal a shift favoring small-cap stocks.

DANBURY, Conn. and BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that United Therapeutics Corporation (Nasdaq: UTHR) has exercised its option—granted under the companies' 2018 license and collaboration agreement—to develop a second dry powder inhalation therapy.

Presenting Data from CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma (r/r pHGG) Patients Presenting Data from CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma (r/r pHGG) Patients

Agnico Eagle Mines Limited (AEM) up 1,004% since Big Money bought big in September 2002.

WILMINGTON, Del., Aug. 27, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq:NRXP), a clinical-stage biopharmaceutical company, today announced its expanded access policy for NRX-100 (preservative-free ketamine) based on grant of Fast Track designation for NRX-100 in the treatment of suicidal ideation in patients with depression, including bipolar depression.

Calgary, Alberta--(Newsfile Corp. - August 27, 2025) - DevvStream Corp. (NASDAQ: DEVS) (the "Company"), a leading carbon management firm specializing in the development, investment, and sale of environmental assets, today announced that on August 22, 2025, it received a notice from The Nasdaq Stock Market, LLC (the "Nasdaq") notifying the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2) and that its common shares, with no par value (the "Common Shares"), continue to be listed and traded on The Nasdaq Capital Market. As previously disclosed, the Company received a staff determination from Nasdaq stating that the bid price …

MongoDB's latest earnings suggest the risk of losing database market share in the artificial-intelligence era might be overblown.

AUSTIN, Texas--(BUSINESS WIRE)--CrowdStrike (NASDAQ: CRWD) today announced it has been named a Leader in the IDC MarketScape: Worldwide Incident Response Services Vendor Assessment. Adversaries are now weaponizing AI to scale operations, accelerate attacks, and target the very AI systems and autonomous agents that are reshaping enterprise environments. Defending against this new era of threats demands partners with deep incident response experience, real-time visibility across diverse systems,.

Abercrombie & Fitch narrowly beat Wall Street's expectations thanks to strong growth at its teen-focused Hollister brand. The company's namesake brand's sales fell 5%, while Hollister grew 19%.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In BellRing Brands (BRBR) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in BellRing Brands and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.

BOULDER, Colo. , Aug. 27, 2025 /PRNewswire/ -- Canopy USA, LLC ("Canopy USA"), a brand-driven organization strategically positioned across the U.S. cannabis market, today announced the appointment of Eric Ruhle as Vice President of Brand Sales, overseeing sales strategy across the full Canopy USA portfolio.

GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company's senior management team will participate in the following investor conferences: Wells Fargo 20 th Annual Healthcare Conference September 4, 20253:00 pm ETWebcast link here One-on-one meetings HCW 27 th Annual Global Investment Conference September 9, 20251:30 PM ETWebcast link here One-on-one meetings Please contact your conference representative to request one-on-one meetings.

Shares of Nvidia Corp. (NASDAQ: NVDA) have surged 38.4% over the past 90 days, including a 3.6% pop in the past week ahead of its earnings report.

Results reinforce telitacicept's potential across multiple autoimmune diseases Data anticipated to be presented at an upcoming medical conference CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that its collaborator, RemeGen Co., Ltd (HKEX: 9995, SHA: 688331), achieved the primary endpoint in Stage A of a Phase 3 clinical study in China evaluating telitacicept in adults with IgA nephropathy (IgAN).

BORDEAUX, France--(BUSINESS WIRE)--HeartFocus, the revolutionary, AI-enabled cardiac imaging software developed by data-driven medtech company DESKi, today announced its U.S. commercial launch. HeartFocus will initially be available on Butterfly Network's handheld ultrasound devices, the FDA-cleared software enables any healthcare professional to conduct diagnostic-quality heart ultrasounds after just hours of training. Health systems, primary care clinics, and clinical education institutions c.

BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will participate in a fireside chat at the upcoming Cantor Global Healthcare Conference on Thursday, September 4 at 3:20pm ET. A webcast of the presentation can be accessed at the following link: https://sqps.onstreamsecure.com/origin/enliven/players/E.

CINCINNATI--(BUSINESS WIRE)--Today, Worldpay® announced it will continue as the exclusive provider of embedded payments for Henry Schein One in a long-term agreement. Since 2004, Worldpay has been the trusted payments partner to Henry Schein One, North America's leading dental software provider serving more than 75,000 practices. This partnership has elevated Henry Schein One's payments business into a powerful driver of revenue and growth while enhancing the experience for its clients and thei.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following upcoming investor conferences: Citi's 2025 Biopharma Back to School Conference on Wednesday, September 3, 2025 at 1:45 pm ET in Boston Morgan Stanley 23rd Annual Global Healthcare Conference on Monday, September 8, 2025 at 1:05 pm ET in New York City Bernstein Insights: Healthcare Leaders and Disru.

BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN or “enGene”), a clinical-stage, non-viral gene therapy company, today announced that management will participate in the following investor conferences in September: 2025 Wells Fargo Healthcare Conference Date: Wednesday, September 3, 2025 Time: 8:45 a.m. ET H.C. Wainwright 27th Annual Global Investment Conference Date: Monday, September 8, 2025 Time: 1:30 p.m. ET Morgan Stanley 23rd Annual Global Healthcare Conference Date:.

Coalition of community leaders creates new initiative that delivers weekly nutritious food, sugar reduction tools, and wellness education to 250 families across Indianapolis CARMEL, Ind. , Aug. 27, 2025 /PRNewswire/ -- Splenda®, a leading global health and wellness brand in sweeteners, has teamed up with Elanco and HATCH, as well as other partners to sponsor Nutrition Secure Indianapolis, a first-of-its-kind program addressing food insecurity and promoting proper nutrition by delivering weekly nutritious food boxes and holistic nutrition support to families across Indianapolis.